Vascular Endothelial Growth Factor, also known as Vascular Permeability Factor, is a multifunctional cytokine hyperexpressed during angiogenesis and in numerous physiological and pathological processes characterised by an increase of vascular permeability. The aim of this study was to evaluate the angiogenetic processes which are accompanied by an expansion of cystic radicular lesions and of keratocysts of the jaw bone. 12 subjects were chosen with an average age of 43 years, of whom 8 were males and 4 females. After an accurate history and physical examination, the patients underwent surgery for removal of the cysts. The samples taken were histologically and immunohistochemical examined. The histological exam confirmed the diagnosis of radicular cysts and keratocysts. The immunohistochemical examinations were positive for VEGF in all the lesions analysed, even though they had different immunostaining. Using a semi-quantitative method, in the radicular cyst samples it was possible to highlight a wider expression of the vascular component, both in the inflamed area and the adjacent stroma. The lesions with keratin content showed newly formed and modest vascularisation both in the area showing slight inflammation, where the cellular component was prevalent, and in the adjacent areas showing no inflammation. Therefore, angiogenesis could take on a primary role in the development of cystic lesions of the jaw. However, the differences of expression of the VEGF protein suggest the need for wider monitoring to better evaluate a possible use of such a protein as a diagnostic marker.
The formation in man of a vascular network may be realised through a process of vasculogenesis and a process of angiogenesis. As described by Reyes and confirmed by Schmeisser and Strasser's researches, vasculogenesis induced the development of a vascular structure during embryonic lifetime through the separation in situ of endothelial progenitors or of angioblasts of mesenchimal derivation, able to unite at a primitive mesenchimal level so as to allow the formation of "immature" blood vessels, which complete themselves at a more advanced stage of development (1) .
Moore has, for a long time, considered angiogenesis as the only mechanism of formation of the vascular structure after birth, through a process of "gemmation" of new blood vessels, starting from a bed of pre-existing capillaries. The formation of new blood vessels has a fundamental biological role in the embryonic life form, while in the adult it is limited to a few physiologic situations, such as remodelling of the extra-osseous matrix, the migration and proliferation of endothelial cells, the differentiation of capillaries and their anastomosis and the process of ovulation (2) .
In the pathological context, the intimate processes correlated to the new vascular formation are different: from the healing of wounds, development and maintenance of chronic inflammatory diseases, and the growth of tumours (3) . A large number of molecules have resulted as being able to regulate and participate in the angiogenetic cascade, both in vivo and in vitro. Among these, the Vascular Endothelial Growth Factor (VEGF) definitely assumes a primary role (4) (5) .
According to numerous studies, the "neoangeogenesis tumour" seems to have a role of primary importance in that the formation of new blood vessels are indispensable for the growth of tumours and for the metastatic diffusion (6) . In fact, the tumour cells, are able to express both proangiogenic factors as well as anti-angiogenesis factors.
In physiological conditions angiogenesis is regulated by the balance between these protein factors, while on the contrary, in malignant conditions, this balance is altered with an increase of the vascular network, a growth of tumour mass and successive metastasis through the internal circulation of the tumour. It has been established that many tumours secrete VEGF in vitro, suggesting the reason why such a molecule might be a mediator of angiogenic tumours.
Studies of hybrids in situ have shown how the VEGF mRNA is highly over-regulated in the vast majority of human tumours, including tumours of the lung (7) , breast (7) (8) , gastrointestinal, kidney (9), bladder (10), ovaries (11) , carcinoma of the uterine cervix, scaly cellular carcinoma of the larynx, and numerous intra-cranial tumours, including both multiform and sporadic glioblastoma (11) (12) , and capillary hemangioblastoma associated with VHL syndrome (13) .
VEGF seems to cover a primary role in angiogenesis of the epithelial odontogenic tumours. As shown in the studies by Kumamoto et. al (14) , a high expression of VEGF is seen both in benign and malignant ameloblastomas. This investigation suggests that the production by epithelial odontogenic cells is over regulated in combination with a neoplastic modification, malignant transformation, or both. In these tumours, VEGF is localised mainly in the neoplastic cells and seems to act on endothelial cells with a paracrine mechanism (15) .
Moreover, Kang underlined how the expression of the angiogenesis factor has a significant correlation with many clinical-pathological aspects of neoplasm of the salivary gland. VEGF, in fact, is associated with several factors, such as the age of the patient, the dimensions of the tumour, the presence of lymphonodal metastasis, perineural invasion, vascular invasion, recurrence and survival (16) . Recent studies (17) have shown how VEGF is involved in the proliferation of solid tumours, not only as a potent chemo-attractor for the preosteoclasts (18) , but also as a molecule able to stimulate osteoclastic differentiation, as well as having a direct effect on the already differentiated osteoclasts (19) .
The destruction of the mineralised bone happens through the action of the osteoclasts, which act on the mineralised matrix of the bone, and through other enzymes such as MMP which acts on the nonmineralised collagen matrix of the bone.
More precisely, the group Matrix Metallo-Proteinase (MMP) is indispensable for the recruitment of other osteoclasts (20) . The synergistic role of the MMP and VEGF in dissolving the calcified matrix in the areas of bone re-absorbency is now well known (19, 21) ; furthermore MMP-9 regulates the proteolysis of the extra-cellular nonmineralised matrix (ECM) resulting in the release of the VEGF contained in the ECM with direct effect on the osteoclasts (22) .
It has been hypothesised that the VEGF and MMP-9 can control the pathological osteolysis of the bone, and that the expression of these cytokine may be co-related with the increase in bone destruction and with localised relapse. Leonardi (32) has underlined VEGF expression in the cystic lesions, though with different intensity, in relation to their process of development.
VEGF, in an initial developmental phase of cystic lesions, is able to assure the neo-formation of vessels and an increase of vascular permeability with the consequence of an overflow of inflamed cells in loco. Successively, it might be involved in the accumulation of cystic fluid with an increase of cellular osteolysis through the expansion of the lesion itself. The aim of our study was to evaluate the VEGF expression in the context of angiogenesis which accompanies the growth of radicular cystic lesions and keratocysts of the jaw bones.
Cysts
Cysts are pathological formations of hard and soft tissue, made up of a central cavity containing liquid, semi-liquid (sebum, keratin, cholesterol) material or simply gaseous. Such structures are bound by a connecting capsule covered by epithelium; in the absence of this epithelia they are known as pseudocysts.
Lacking autonomous growth, since they are benign, their expansion is due to an increase in the content and therefore from intra-cystic pressure with the consequence of a compression of the membrane and ofthe neighbouring tissues. This mechanism can sometimes determine the disruption and/or reabsorption of the nearby tissues. The cystic cavity grows in a centrifugal direction thanks to the presence of loci minoris resistentiae, such as the nasal cavity, maxillary sinuses, and lower mandible canal. If not treated, they can perforate the hard tissue, and raise the soft tissue (33) .
On the basis of the OMS classification of 1992 (34) it is possible to distinguish:
-Disembriologic Cysts (whether odontogenic or not) -Inflamed Cysts -Pseudo Cysts -Calcified Odontogenic Cysts with solid variants (classified as benign tumours) MATERIALS AND METHODS 12 Subjects were chosen with an average age of 43, (8 male and 4 female). An accurate history, and an exact oral examination were carried out, after which the patients were submitted to surgery for cyst removal. For the histological exam the samples were fixed in neutral formaline tampon at 10% for 24 hours and successively immersed in paraffin through TISSUE-TEX VIP E 150. Each one was submitted to an histological sectioning of 3 microns through a rotary microtome LEITZ 1512, coloured with hematoxilin-eosin (hematoxilin by Mayer and eosin by G. BIO-OPTICA) and evaluated through an optic microscope Leica DMRB.
The histological exams defined the diagnosis of 6 radicular cysts and the same number of keratocysts. The samples obtained were positioned on glass slides and electrically charged to perform an immunoistochemical analysis, using the StrepABC (streptavidine-biotinperoxidase) method. A microwave oven was used to reveal the antigens after having covered the sections with citric acid at 2.1% (pH6), incubated in a solution containing the primary antibody for 30 minutes at ambient temperature and finally automatically coloured (OPTOMAX-BIOGENEX).
The samples obtained were washed with a tampon solution and the immune reaction was finalised through the StrepABC peroxidase method, utilising the "Super Sensitive Immunodetection System" kit from BIOGENEX and a multi-link as a secondary antibody. After incubating with a chromogen (liquid DAB substrate pack), the samples were highlighted using hematoxilineosin by Mayer.
For the immunohistochemical study, rabbit polyclonal antibody A-20 was used against a human amino-terminal epitope of the VEGF (Santa Cruz Biotechnology, Santa Cruz, CA). The vascular density was established on coloured sections with VEGF through a semiquantitative scale of low, medium and high.
RESULTS
The results of the immunohistochemical study in the radicular cyst and in the keratocyst lesions have allowed us to verify a different intensity of the VEGF evaluated by a semiquantitative analysis, as summarized in the Table I .
Radicular Cysts
Regarding radicular cysts, a microscopic observation has clearly shown the positiveness of VEGF on the internal side of the epithelial component; it has been further observed, in the context of the cystic wall, a wide inflammatory infiltration made up prevalently of lymphocytes, plasmacells and granulocytes. The immunohistochemical method using polyclonal antibody anti-VEGF A-20, has revealed a neovascular formation both in the internal area of the inflammation, as well as in the underlying tissue. When further enlarged it was possible to demonstrate an excess neovascular response in respect to the infiltrated inflamed cells. In the underlying stroma, free from inflammation, an excessive neo-vascularity has been confirmed, accompanied by a higher expression of the VEGF, not only on the part of the well formed microvessels, but also by the numerous endothelial cells. Furthermore, in all the sections examined, there was an intense immunohistochemical positivity towards the VEGF co-expressed by the fibroblast component. In the morphological evaluation of the radicular cysts a papillomatosis aspect of the epithelial component with the presence of cholesterol crystals has been encountered, characteristics not seen in keratocysts, and therefore useful for differential diagnosis.
Keratocysts
In keratocysts, the histological evaluation with polyclonal antibodies anti-VEGF A-20, demonstrated general characteristics similar to those already described. Nevertheless, the antibody expression presented a minor intensity in all the sections. When further enlarged, within the area of the inflammatory process, the cellular components are prevalent, with respect to the vascular component. In the underlying stromal tissue, it was possible to demonstrate a reduction in the cellular density and a weaker process of neo-angiogenesis. Microscopic observation demonstrated a clear positivity of the epithelial component and less immunohistochemical response than in fibroblasts. No papillomatosis aspect of the epithelial component has been found, furthermore, on the inside of the samples examined, there was a total absence of cholesterol crystals.
DISCUSSION
According to the literature, there are numerous cells able to express angiogenic factors, both in physiological and pathological processes in different types of tissues. In this study angiogenesis was evaluated through the expression of VEGF connected to the expansive growth of radicular cystic lesions and of keratocysts of the jaw bone. Angiogenesis is a complex process responsible for the formation and budding of new vessels starting from the existing microcirculation; such a phenomenon comprises migration and proliferation of endothelial cells, differentiation of the capillaries and their anasthomosis, reshaping of the extra-bone matrix. The angiogenic process is characterised by diverse conditions, such as: wound healing, chronic inflammatory conditions and tumour growth. Chronic pathological conditions, where neoangiogenetic processes are involved, are: proliferative retinopathies, macular degeneration due to age (AMD), diabetes, rheumatoid arthritis and psoriasis. The development, expansion and diffusion of tumour processes are closely linked to vascular neo-formation phenomena. Numerous mechanisms able to regulate tumour angiogenesis have been proposed as follows:
Secretion of endothelial growth factors, of which VEGF (23-26) results to be the most potent and specific protein with intracellular action, is able to stimulate tyrosine kinase activity in endothelial cells; the down-regulation of natural inhibitors of angiogenesis (27) ; the activation of the precursors of circulating CD34+ endothelial cells able to contribute to vasculogenesis through mechanisms, as yet unknown, which mainly involve genetic control (28) (29) . With the angiogenic change there follows a cascade of biological effects on the activated endothelial target: retraction of pericytic, over-expression of new genes or down-regulation of others and secretion of determined growth factors (FGF, IGF-l, IL-6) which can act through autocrine or paracrine mechanism (30) (31) . An important role is given to hypoxia which induces the VEGF, from its specific receptor, with an increase in macrophage infiltration.
In the neoplastic process, hypoxia may induce an increase in distance between growing tumour cells and capillary vessels or from an inefficiency of the newly formed vessels. Studies on hybridisation in situ have shown how VEGF-mRNA is highly over controlled in the majority of human tumours, amongst them tumours of the lung (7) , breast (7) (8) , gastrointestinal tract, kidney (9) , bladder (10) , ovaries (11) , carcinoma of the endometrium, uterine cervix, scaly cell carcinoma of the larynx, and numerous intra-cranial tumours such as multiform and sporadic glioblastoma (11) (12) and the capillary hemangioblastoma associated with VHL (13) syndrome.
VEGF, moreover, seems to have a primary role in angiogenesis of the epithelial odontogenic tumours (14) and in the neoplasms of the salivary glands, in fact, it is present in association with neo-plastic modifications of the tissues or malign transformation of the same (15) . Numerous studies (17) have shown, how the VEGF is involved in the proliferation of solid tumours and in the expansion of osteolytic lesions of the jaw bones, through a strong chemioattractor function to the pre-osteoclasts (18), even stimulating their differentiation. This mechanism is a mediator of the Matrix Metallo Proteinases (MMP), indispensable for the recruitment of osteoc1asts in strict synergism with VEGF (19, (21) (22) .
Our study has revealed the presence of the VEGF protein in all the human samples of maxillary cysts examined , although at different expression levels. It was possible to evaluate how, in the inflamed area of radicular cysts, the vascular component is exuberant in respect to the inflammatory cell infiltrate. In the underlying stroma, an extensive vascular proliferation with a marked VEGF expression has been confirmed , not only on the inside of the endothelial cells of well structured microvessels but also inside single endothelial buttons. A marked positivity has been observed for the fibroblast component on the inside of the examined samples . The examination of the odontogenic keratocyst showed an inferior immunohistochemical positivity both for the fibroblast and for the endothelium. A moderate immunohistochemical reaction was observed in structured micro-vessels with the presence of sporadic inflammatory cells.
The study of numerous protein factors involved in the genesis of the vascular system, highlights the role of VEGF in the context of multiple passages of the physiological or pathological tissue development. Furthermore, the monoclonal antibody Bevacizumab (Avastin ), specific for VEGF, was shown to inhibit the neo-angiogenesis phenomenon and to block the growth of tumor cells in nude mice. Our study revealed the presence of VEGF on the inside of all the radicular cyst and keratocyst samples examined, although with different intensity.
Immunohistochemical analysis determined the presence of single endothelial buttons markedly positive for VEGF, from which, through a process of gemmation , new vascular structures could originate . Finally, it is hypothesised that vascular neoformation might initiate from single fibroblasts marked by VEGF, able to differentiate successively into endothelial cells. Therefore, our observations hypothesise a cardinal role in the process of neoangiogenesis in the development of cysts, controlled by specific proteins of genetic derivation able to carry out a specific function of key regulators.
